Formac Pharmaceuticals

company

About

Formac is a drug delivery company focused on the formulation of poorly soluble active pharmaceutical ingredients.

  • 1 - 10

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
€1.70M
Industries
Biotechnology,Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 2007
Number Of Employee
1 - 10
Operating Status
Active

Formac is a spin-off company from the University of Leuven, Belgium (K.U.Leuven), from which it has obtained the exclusive and worldwide rights to develop and commercialise ordered mesoporous silica materials for the delivery of poorly soluble API's. The company was incorporated on 3 October 2007 and is privately owned. The main shareholders of Formac are K.U.Leuven, Allegro Investment Fund, Hunza Ventures, Gemma Frisius Fonds K.U.Leuven, Vinnof PMV and Life Sciences Research Partners VZW (formerly D. Collen Foundation).

Since its incorporation Formac has signed more than 40 feasibility agreements with Tier 1 Pharma companies and SMEs in the field of human and veterinary medicine. To date, Formac is the only company that demonstrated the clinical relevancy of the silica based technology in a clinical setting.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€1.70M
Formac Pharmaceuticals has raised a total of €1.70M in funding over 2 rounds. Their latest funding was raised on Nov 8, 2007 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 8, 2007 Series Unknown €1.70M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Formac Pharmaceuticals is funded by 1 investors. Vinnof are the most recent investors.
Investor Name Lead Investor Funding Round
Vinnof Series Unknown